Search results
Results From The WOW.Com Content Network
Nicolae Constantin Paulescu (Romanian pronunciation: [nikoˈla.e pa.uˈlesku]; 30 October 1869 (O.S.) – 17 July 1931) was a Romanian physiologist, professor of medicine, and politician, most famous for his work on diabetes, including patenting pancreine (a pancreatic extract containing insulin).
Hagedorn discovered that the addition of protamine to insulin caused the insulin to form microscopic clumps. These clumps took longer to dissolve into the bloodstream. This complex of protamine and insulin is known as NPH (neutral protamine Hagedorn) insulin. It is one of the earliest example of engineering drug delivery.
Insulin pumps, cartridges, and infusion sets may be far more expensive than syringes used for insulin injection with several insulin pumps costing more than $6,000; necessary supplies can cost over $300. [3] Another disadvantage of insulin pump use is a higher risk of developing diabetic ketoacidosis if the pump malfunctions. [3]
Physicians had no way to treat their diabetic patients’ dangerously high blood sugar levels, which were due to a lack of the hormone insulin. Today, though, nearly 1.6 million Americans
From Banting's viewpoint, "this was a brazen coup by Macleod to rob him of the credit for having discovered insulin – and to rub salt into the wound, it had been done in front of the most eminent doctors in the field". [14] Their discovery was first published in the February 1922 issue of The Journal of Laboratory and Clinical Medicine. [15]
In October 1923, Banting and Macleod were awarded the Nobel Prize in Physiology based on a nomination by August Krogh for "the discovery of insulin and their exploration of its clinical and physiological characteristics". [123] [124] [125] Banting and Macleod publicly shared the prize with Best and Collip, respectively. [126] [127] [128] [129]
People with type 1 diabetes who wear insulin pumps should know that altitude changes during air travel can cause unintended insulin delivery, researchers said at the diabetes meeting in Madrid.
Much of this extended protection also came from the more than 100 patents that were filed by insulin manufacturers after a drug or delivery tool had already been approved by the FDA, a timeline ...